Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood

• Publication date

  2010-11-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2010-02-269571PMID 20664060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia

  2009cited by this paper
• Hematopoietic stem cell transplantation from unrelated donors for acute leukemia.

  2008cited by this paper
• Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.

  2008influential reference
• Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival.

  2007cited by this paper
• Competing risk analysis using R: an easy guide for clinicians

  2007cited by this paper
• Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.

  2007cited by this paper
• Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome

  2007cited by this paper
• In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: fin

  2006cited by this paper
• Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Ce

  2006cited by this paper
• Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.

  2005cited by this paper
• Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia.

  2005cited by this paper
• Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

  2005cited by this paper
• Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease

  2005cited by this paper
• Interstitial Lung Disease Induced by Drugs and Radiation

  2004cited by this paper
• Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.

  2004cited by this paper
• A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome.

  2003cited by this paper
• Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

  2002cited by this paper
• Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation

  2001cited by this paper
• Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome.

  2001influential reference
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

  1999influential reference
• Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

  1999cited by this paper
• Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

  1999cited by this paper
• 1994 Consensus Conference on Acute GVHD Grading.

  1995cited by this paper
• Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia.

  1991cited by this paper
• Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories.

  1989cited by this paper
• Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors.

  1986cited by this paper
• Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

  1981cited by this paper
• Asymptotically Efficient Rank Invariant Test Procedures

  1972cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Importance of measurable residual disease in the outcome of adults with acute lymphoblastic leukemia after allogeneic stem cell transplantation: Long follow-up analysis from a single transplant center.

  2024cites this paper
• Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia: Results of a Single-Center Study

  2024cites this paper
• Younger Matched Unrelated Donors Confer Decreased Relapse Compared to Older Sibling Donors in Older B-cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

  2023cites this paper
• Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia

  2022cites this paper
• Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.

  2022cites this paper
• Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

  2022cites this paper
• Unmanipulated haploidentical peripheral blood stem cell transplantation for patients with Philadelphia-negative acute lymphoblastic leukaemia in first complete remission

  2020cites this paper
• S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukaemia

  2019cites this paper
• Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia.

  2018influential citation
• Diagnostic value of highly-sensitive chimerism analysis after allogeneic stem cell transplantation

  2018cites this paper
• Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present state

  2018cites this paper
• Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies.

  2018cites this paper
• The Role of Allograft in Acute Lymphoblastic Leukaemia, Including Alternate Donors

  2017cites this paper
• Current challenges and opportunities in treating adult patients with Philadelphia‐negative acute lymphoblastic leukaemia

  2017cites this paper
• Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard‐risk acute lymphoblastic leukaemia in first complete remission

  2017cites this paper
• Who Should Receive a Transplant for Acute Lymphoblastic Leukaemia?

  2017cites this paper
• Thiotepa‐based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

  2017cites this paper
• Pediatric‐inspired therapy compared to allografting for Philadelphia chromosome‐negative adult ALL in first complete remission

  2016cites this paper
• Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older

  2016cites this paper
• Clinical updates in adult acute lymphoblastic leukemia.

  2016cites this paper
• Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies

  2016cites this paper
• Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation in First Complete Remission Can Abrogate the Poor Outcomes of Children with Acute Myeloid Leukemia Resistant to the First Course of Induction Chemotherapy.

  2016cites this paper
• Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning

  2015cites this paper
• Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia‐negative acute lymphoblastic leukemia: No difference in the high‐ and low‐risk groups

  2015influential citation
• 单倍型造血干细胞移植治疗成人急性淋巴细胞白血病

  2015cites this paper
• Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: Myeloablative, non-myeloablative, and beyond

  2015cites this paper
• Leucémies aiguës lymphoblastiques de l’adulte

  2015cites this paper
• Role of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia

  2014cites this paper
• Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

  2014cites this paper
• Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults

  2014cites this paper
• Predictors of outcome in adults with BCR-ABL negative acute lymphoblastic leukemia treated with a pediatric-based regimen.

  2014cites this paper
• Tratamiento de rescate de leucemia aguda refractaria o en recaída con el régimen IDA-FLAG: experiencia en la rutina de los servicios

  2014cites this paper
• [111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 18. Recent advance and challenge of hematopoietic stem cell transplantation].

  2014cites this paper
• Novel agents and biomarkers for acute lymphoid leukemia

  2013cites this paper
• Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

  2013cites this paper
• Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?

  2013cites this paper
• Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission

  2013cites this paper
• Przeszczepienie krwiotwórczych komórek macierzystych w leczeniu ostrej białaczki limfoblastycznej u dorosłych Hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in adults

  2012cites this paper
• Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults

  2012cites this paper
• Allogeneic stem cell transplant for adult Philadelphia chromosome-negative acute lymphoblastic leukemia

  2012cites this paper
• When, how, and what cell source for hematopoietic cell transplantation in first complete remission adult acute lymphoblastic leukemia?

  2012cites this paper
• Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults

  2011cites this paper
• Update in Haematopoietic Stem Cell Transplantation

  2011cites this paper
• Cellular therapies in acute lymphoblastic leukemia.

  2011cites this paper
• Advances in acute lymphoblastic leukemia in adults

  2011cites this paper
• Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.

  2011cites this paper
• Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia

  2011cites this paper
• Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how

  2011cites this paper
• Cellular therapies in acute lymphoblastic leukemia.

  2009cites this paper